Glooko is a digital health platform that helps people with diabetes and other chronic conditions manage their health by integrating data from a wide range of devices, mobile apps, and electronic health records. The platform is designed for both patients and healthcare providers, offering tools for real-time glucose tracking, remote monitoring, personalized insights, and clinical decision support.
Used by over 3 million people in more than 30 countries, Glooko supports patients with diabetes, obesity, hypertension, and related metabolic conditions. Its ability to unify data from over 200 devices—including glucose meters, insulin pumps, continuous glucose monitors (CGMs), fitness trackers, and blood pressure monitors—makes it one of the most comprehensive solutions in the digital diabetes care space.
Glooko is HIPAA- and GDPR-compliant, ensuring that personal health information is managed with the highest levels of security and privacy.
Features
Device Integration: Glooko connects with more than 200 health devices and wearables, including popular brands like Dexcom, Abbott, Medtronic, Omron, Fitbit, and Apple Health, offering a unified view of patient data.
Remote Patient Monitoring: The platform allows clinicians to track patient health remotely, view real-time trends, and adjust treatment plans based on continuous input from synced devices.
Mobile App for Patients: Glooko’s intuitive mobile app enables users to log food, activity, insulin, and medication data alongside device-generated metrics to understand how lifestyle factors affect glucose levels.
Population Health Management: Healthcare providers can manage large patient populations using dashboards that highlight trends, out-of-range alerts, and actionable insights.
Automated Reports and Insights: The system generates personalized reports and predictive insights that help patients and providers optimize glycemic control and improve long-term outcomes.
EHR Integration: Glooko integrates with major electronic health record systems, enabling seamless data flow between clinical systems and the Glooko platform.
Multilingual and Global Access: Glooko is available in multiple languages and supports global deployments, with regional partnerships in North America, Europe, the Middle East, and Asia.
Clinical Research Tools: Glooko offers solutions for life sciences companies conducting clinical trials or observational studies, supporting real-world data collection and analysis.
AI-Powered Predictive Tools: The platform is enhancing its offerings with artificial intelligence capabilities for risk stratification, predictive alerts, and automated patient coaching.
How It Works
Glooko starts with account setup via its mobile app or through a healthcare provider invitation. Patients sync their diabetes devices and wearables with the platform using Bluetooth, USB adapters, or cloud connections.
Once synced, data is automatically pulled into the Glooko ecosystem and displayed in visual dashboards that show glucose trends, insulin usage, carb intake, physical activity, and more. The app allows manual logging of meals, sleep, and medications for a more complete picture of health.
Clinicians access the Glooko web dashboard to monitor patient data remotely, set personalized targets, and send feedback. For population management, care teams can filter patient lists by key risk factors such as hypoglycemia episodes or out-of-range glucose readings.
Through continuous data collection and AI-powered analysis, Glooko helps improve clinical decisions, reduce hospitalizations, and empower patients to take control of their chronic condition.
Use Cases
Endocrinology clinics use Glooko to streamline data collection during visits and enable proactive interventions between appointments.
Primary care providers use the platform to monitor diabetic patients remotely and optimize medication management.
Hospitals and health systems use Glooko for population health initiatives to reduce diabetes-related readmissions and emergency visits.
Pharmaceutical companies leverage Glooko to support digital companion programs, gather real-world evidence, and enhance clinical trial monitoring.
Employers and health plans incorporate Glooko into wellness programs to improve outcomes and lower chronic disease management costs.
Researchers use Glooko to collect real-world data on patient behavior, treatment adherence, and clinical outcomes in diabetes management.
Pricing
Glooko does not publicly list pricing on its website, as offerings vary based on the customer type—such as healthcare providers, life sciences organizations, or enterprise partners.
The pricing model typically depends on:
Number of patients or users
Features selected (e.g., remote monitoring, predictive analytics)
Integration needs (EHR systems, device data flow)
Clinical research or enterprise-level customization
Geographic deployment and support requirements
Individual patients may access Glooko through a clinic or health plan partnership. In some regions, a limited version of the mobile app is available for direct use, free of charge.
Organizations interested in pricing or pilot programs are encouraged to contact the Glooko sales team directly for a tailored quote.
Strengths
Glooko offers unmatched interoperability by supporting over 200 diabetes and health devices, giving patients and providers a unified data platform.
Its HIPAA- and GDPR-compliant infrastructure ensures strong data security and regulatory alignment, making it suitable for global deployments.
The platform supports remote care, which is especially valuable in managing chronic conditions like diabetes that require frequent monitoring.
Glooko’s AI-powered features and data-driven insights help improve clinical outcomes and support personalized treatment plans.
It is widely adopted by both academic health centers and large healthcare systems, reinforcing its reliability and scalability.
The solution supports both clinical and research use cases, making it versatile for providers, life sciences, and digital health innovators.
Drawbacks
Glooko is primarily designed for institutional use, and many of its most powerful features are only available through provider or enterprise subscriptions.
Initial setup for integration with EHRs and devices may require technical support, which could be a barrier for smaller practices.
While the mobile app supports individual users, some features may be limited without access through a healthcare provider or premium partnership.
Users without compatible devices may not experience the full benefits of Glooko’s ecosystem.
Pricing information is not publicly disclosed, which may delay decision-making for potential clients.
Comparison with Other Tools
Glooko is often compared with other digital diabetes management platforms like Livongo, mySugr, and One Drop.
Livongo, now part of Teladoc Health, offers connected glucose meters and coaching programs but is more focused on employer wellness solutions. Glooko supports a wider range of devices and is built for both clinical and research environments.
mySugr is primarily a consumer-focused app owned by Roche, centered around glucose logging and gamification. Glooko offers more advanced data integration and enterprise tools for providers and researchers.
One Drop combines device support with predictive insights and coaching. Glooko differentiates itself by supporting multiple device types, offering EHR integration, and serving both B2C and B2B clients at scale.
Glooko’s strength lies in its device-agnostic approach, clinical-grade analytics, and use across patient, provider, and research channels.
Customer Reviews and Testimonials
Glooko is used by over 3 million people worldwide, including patients, providers, and researchers across diverse healthcare settings.
Healthcare professionals praise Glooko for streamlining chronic care workflows, reducing in-person visits, and improving patient engagement.
Patients appreciate the app’s ease of use, data syncing capabilities, and ability to see how lifestyle choices affect glucose levels in real time.
Leading institutions such as Joslin Diabetes Center and Mayo Clinic have adopted Glooko in clinical care and research projects.
Clinical studies show that Glooko usage correlates with better glycemic control, fewer hospitalizations, and higher treatment adherence.
Conclusion
Glooko is a powerful digital health platform that simplifies chronic disease management by connecting patients, providers, and data in a unified ecosystem. With its extensive device compatibility, secure infrastructure, and intelligent analytics, Glooko helps deliver better outcomes for people with diabetes and other metabolic conditions.
Whether deployed in a hospital, clinic, research study, or home care setting, Glooko enhances transparency, encourages adherence, and supports smarter, more personalized care.
